Drug giant Pfizer Inc. said it is planning to relocate the majority of its 530 employees at research facilities in the Alewife neighborhood of Cambridge to Kendall Square in Cambridge; sometime next year, they will join roughly 400 Pfizer employees who are already working in Kendall Square, a hotbed of the life sciences industry. Syros Pharmaceuticals, a newly launched company in Watertown that seeks to harness breakthroughs in gene control to treat cancer and other diseases, said Wednesday that it has completed a $30 million Series A financing led by company cofounders Arch Venture Partners and Flagship Ventures. Nurses holding signs and decked in blue coats marched in front of Quincy Medical Center on Thursday morning, shouting demands for increased staffing and chanting in unison about allegedly unsafe patient conditions. Bristol-Myers Squibb, a global biopharmaceutical company, announced plans Thursday for a $250 million expansion of its large-scale biologics manufacturing facility in Devens. The expansion will introduce biologics development and clinical trial manufacturing capabilities to the site, while eventually adding about 350 employees to the Devens workforce, the company said in a press release. The current head count at Devens is about 400. Cydan LLC of Cambridge announced its launch with $16 million in financing. Cydan plans to focus on rare diseases and help acclerate the development and commercialization of the so-called orphan drugs designed to treat rare diseases. A rare and orphan disease is generally one that affects fewer than 200,000 patients — or about 1 in 1,500 people — in the US. TJX Cos., the Framingham company that operates such off-price retail chains as T.J. Maxx, Marshalls, and HomeGoods, reported that sales for the five-week period that ended April 6 were $2.4 billion, up 5 percent over the same period a year ago. Winthrop Realty Trust has sold a 92,700-square-foot data center in Andover to Carter Validus Mission Critical REIT Inc. for $12 million, said a broker involved in the transaction. | | |
No comments:
Post a Comment